VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1605024
Sex: M
Age: 52
State: FL

Vax Date: 03/09/2021
Onset Date: 03/10/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tested positive for COVID19 Virus; Started feeling really bad; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID19 Virus) and FEELING ABNORMAL (Started feeling really bad) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced FEELING ABNORMAL (Started feeling really bad). On 15-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID19 Virus). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID19 Virus) and FEELING ABNORMAL (Started feeling really bad) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Mar-2021, SARS-CoV-2 test: (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. However, based on the mechanism of action mRNA-1273 causal association between the event of COVID-19 Test positive and mRNA-1273 is assessed as not applicable.

Other Meds:

Current Illness:

ID: 1605025
Sex: F
Age: 67
State: AL

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (extreme fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 014M20A) for COVID-19 vaccination. The patient's past medical history included Hypersomnia since an unknown date. Concomitant products included LISINOPRIL, LEVOTHYROXINE SODIUM (SYNTHROID) and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced FATIGUE (extreme fatigue). The patient was treated with AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) at an unspecified dose and frequency. On 14-Feb-2021, FATIGUE (extreme fatigue) had resolved. Action taken with mRNA-1273 in response to the event was not applicable. This case was linked to US-MODERNATX, INC.-MOD-2021-063561 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-063561:Dose 1

Other Meds: LISINOPRIL; SYNTHROID; CRESTOR

Current Illness: Hypersomnia

ID: 1605026
Sex: F
Age: 90
State: FL

Vax Date: 03/28/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: very itchy in those portions; hot all over, mostly the face and top of legs; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (very itchy in those portions) and FEELING HOT (hot all over, mostly the face and top of legs) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (very itchy in those portions) and FEELING HOT (hot all over, mostly the face and top of legs). The patient was treated with CEFALEXIN (KEFLEX [CEFALEXIN]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PRURITUS (very itchy in those portions) and FEELING HOT (hot all over, mostly the face and top of legs) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Additional information received

Other Meds:

Current Illness:

ID: 1605027
Sex: F
Age: 61
State: OH

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: soreness in arm that moved to collar bone; heaviness; as the night went on it was a little heavy and sore and soreness went into collar bone and a little fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness in arm that moved to collar bone), LIMB DISCOMFORT (heaviness) and FATIGUE (as the night went on it was a little heavy and sore and soreness went into collar bone and a little fatigue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. No Medical History information was reported. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PAIN (soreness in arm that moved to collar bone), LIMB DISCOMFORT (heaviness) and FATIGUE (as the night went on it was a little heavy and sore and soreness went into collar bone and a little fatigue). On 10-Mar-2021, PAIN (soreness in arm that moved to collar bone), LIMB DISCOMFORT (heaviness) and FATIGUE (as the night went on it was a little heavy and sore and soreness went into collar bone and a little fatigue) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided Treatment for the events were not provided This case was linked to MOD-2021-070615 (Patient Link).

Other Meds:

Current Illness:

ID: 1605028
Sex: F
Age: 92
State: PA

Vax Date: 01/26/2021
Onset Date: 03/05/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: the following day had a rash on the back and legs and it itches; little red bumps appeared and it itches like crazy, severely on the back and top of the tights; the following day had a rash on the back and legs and it itches; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (the following day had a rash on the back and legs and it itches), MASS (little red bumps appeared and it itches like crazy, severely on the back and top of the tights) and RASH (the following day had a rash on the back and legs and it itches) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 013A21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced PRURITUS (the following day had a rash on the back and legs and it itches) and RASH (the following day had a rash on the back and legs and it itches). 05-Mar-2021, the patient experienced MASS (little red bumps appeared and it itches like crazy, severely on the back and top of the tights). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (the following day had a rash on the back and legs and it itches), MASS (little red bumps appeared and it itches like crazy, severely on the back and top of the tights) and RASH (the following day had a rash on the back and legs and it itches) outcome was unknown. Products known to have been used by the patient, within two weeks prior to the event were not provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable This case was linked to MOD-2021-036136 (Patient Link).

Other Meds:

Current Illness:

ID: 1605029
Sex: F
Age: 73
State: MA

Vax Date: 03/01/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I couldn't eat.; fever; Chills; Headaches; so bad that it was hard to put my head on the pillow. The headaches were the most; Patient wanted us to know that it was the severity of the headache that bothered me.; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DECREASED APPETITE (I couldn't eat.), PYREXIA (fever), CHILLS (Chills), HEADACHE (Headaches; so bad that it was hard to put my head on the pillow. The headaches were the most) and HEADACHE (Patient wanted us to know that it was the severity of the headache that bothered me.) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (I couldn't eat.), PYREXIA (fever), CHILLS (Chills), HEADACHE (Headaches; so bad that it was hard to put my head on the pillow. The headaches were the most) and HEADACHE (Patient wanted us to know that it was the severity of the headache that bothered me.). At the time of the report, DECREASED APPETITE (I couldn't eat.), CHILLS (Chills), HEADACHE (Headaches; so bad that it was hard to put my head on the pillow. The headaches were the most) and HEADACHE (Patient wanted us to know that it was the severity of the headache that bothered me.) outcome was unknown.

Other Meds:

Current Illness:

ID: 1605030
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: React badly; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an attorney and describes the occurrence of ADVERSE DRUG REACTION (React badly) in a not specific patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Multiple sclerosis. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (React badly). At the time of the report, ADVERSE DRUG REACTION (React badly) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness: Multiple sclerosis

ID: 1605031
Sex: F
Age: 50
State: RI

Vax Date: 03/25/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (arm pain for about 3-4 days), migraine headache, back pain (back pain and neck pain, pretty severe), neck pain (back pain and neck pain, pretty severe) and decreased mobility (she couldn't hardly move) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Mar 25, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced pain in extremity (arm pain for about 3-4 days), migraine headache, back pain (back pain and neck pain, pretty severe), neck pain (back pain and neck pain, pretty severe), decreased mobility (she couldn't hardly move), chills (shivers) and pyrexia (mild temperature at 98). At the time of the report, pain in extremity (arm pain for about 3-4 days), migraine headache, back pain (back pain and neck pain, pretty severe), neck pain (back pain and neck pain, pretty severe), decreased mobility (she couldn't hardly move), chills (shivers) and pyrexia (mild temperature at 98) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant medications and treatment details not reported.

Other Meds:

Current Illness:

ID: 1605032
Sex: M
Age: 48
State: CA

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: feeling unwell; pain in the legs and feet; oxygen level of 91; fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling unwell), PAIN IN EXTREMITY (pain in the legs and feet), OXYGEN SATURATION (oxygen level of 91) and PYREXIA (fever) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027b21a) for COVID-19 vaccination. No Medical History information was reported. On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced MALAISE (feeling unwell), PAIN IN EXTREMITY (pain in the legs and feet), OXYGEN SATURATION (oxygen level of 91) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 2 dosage form. At the time of the report, MALAISE (feeling unwell), PAIN IN EXTREMITY (pain in the legs and feet), OXYGEN SATURATION (oxygen level of 91) and PYREXIA (fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications are not provided by the reporter.

Other Meds:

Current Illness:

ID: 1605033
Sex: F
Age: 34
State: IL

Vax Date: 03/15/2021
Onset Date: 03/15/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pregnant female received Moderna Covid-19 Vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant female received Moderna Covid-19 Vaccine) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0011B21A) for COVID-19 vaccination. No Medical History information was reported. On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 09-Jul-2020 and the estimated date of delivery was 15-Apr-2021. On 15-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant female received Moderna Covid-19 Vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the thirty-fifth week of the pregnancy. On 15-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant female received Moderna Covid-19 Vaccine) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication details were reported. No treatment medication details was reported.

Other Meds:

Current Illness:

ID: 1605034
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Adverse event NOS; This spontaneous case was reported and describes the occurrence of ADVERSE EVENT (Adverse event NOS) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Adverse event NOS). At the time of the report, ADVERSE EVENT (Adverse event NOS) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant product was reported. No treatment information was reported. Case was received via email with limited information.

Other Meds:

Current Illness:

ID: 1605035
Sex: U
Age:
State:

Vax Date: 02/01/2021
Onset Date: 04/05/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tested positive for Covid; lack of effect; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for Covid) and DRUG INEFFECTIVE (lack of effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced COVID-19 (Tested positive for Covid) and DRUG INEFFECTIVE (lack of effect). At the time of the report, COVID-19 (Tested positive for Covid) had not resolved and DRUG INEFFECTIVE (lack of effect) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive. Concomitant product use was not provided. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: Upon internal review on 06-Aug-2021, an event (lack of effect) was added.

Other Meds:

Current Illness:

ID: 1605036
Sex: F
Age: 61
State: OH

Vax Date: 03/08/2021
Onset Date: 04/05/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe cramping; Low grade fever; muscle aches; Fatigue; headache; Chills; explosive watery diarrhea; Nausea; left arm is heavy, sore and has a knot on it; left arm is heavy, sore and has a knot on it; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm is heavy, sore and has a knot on it), INJECTION SITE MASS (left arm is heavy, sore and has a knot on it), MUSCLE SPASMS (Severe cramping), DIARRHOEA (explosive watery diarrhea) and NAUSEA (Nausea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced PAIN IN EXTREMITY (left arm is heavy, sore and has a knot on it), INJECTION SITE MASS (left arm is heavy, sore and has a knot on it), DIARRHOEA (explosive watery diarrhea), NAUSEA (Nausea), MYALGIA (muscle aches), FATIGUE (Fatigue), HEADACHE (headache) and CHILLS (Chills). On 06-Apr-2021, the patient experienced MUSCLE SPASMS (Severe cramping) and PYREXIA (Low grade fever). On 07-Apr-2021, DIARRHOEA (explosive watery diarrhea), PYREXIA (Low grade fever) and CHILLS (Chills) had resolved. At the time of the report, PAIN IN EXTREMITY (left arm is heavy, sore and has a knot on it), INJECTION SITE MASS (left arm is heavy, sore and has a knot on it), MUSCLE SPASMS (Severe cramping), NAUSEA (Nausea), MYALGIA (muscle aches), FATIGUE (Fatigue) and HEADACHE (headache) had not resolved. Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter. This case was linked to MOD-2021-070515, MOD-2021-070515 (Patient Link).

Other Meds:

Current Illness:

ID: 1605037
Sex: F
Age: 22
State: OH

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pregnant and received 1st dose; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant and received 1st dose) in a 22-year-old female patient (gravida 3, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025b21a) for COVID-19 vaccination. The patient's past medical history included Pregnancy (Craniosynostosis with youngest child). Concurrent medical conditions included Allergic reaction to antibiotics, Allergic reaction to antibiotics, Allergic reaction to antibiotics and Drug allergy. Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE], ESCITALOPRAM OXALATE (LEXAPRO) and CLONAZEPAM (KLONOPIN) for an unknown indication. On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 12-Jun-2021. On 07-Apr-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant and received 1st dose). On 07-Apr-2021, EXPOSURE DURING PREGNANCY (Pregnant and received 1st dose) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Laboratory test includes Dating ultrasound-Normal , Anatomy ultrasound-Normal, Ultrasound to look for Craniosyntosis- Normal . Medical history include Craniosyntosis with youngest child. Concomitant medication include iron supplement. No treatment information was provided.

Other Meds: PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS ; LEXAPRO; KLONOPIN

Current Illness: Allergic reaction to antibiotics; Drug allergy

ID: 1605038
Sex: F
Age:
State: OR

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous prospective pregnancy case reported by a consumer, describes the occurrence of maternal exposure during pregnancy (pregnant patient received 2 vaccines) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Feb 12, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 12, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was Jul 23, 2021. On Feb 12, 2021, patient experienced maternal exposure during pregnancy (pregnant patient received 2 vaccines). On Mar 12, 2021, maternal exposure during pregnancy (pregnant patient received 2 vaccines) resolved. Diagnostic results: On an unknown date: Pregnancy test: Positive. On an unknown date, Ultrasound scan: Normal. No concomitant medication or treatment information reported. Patient reported an ultrasound was completed on an unknown date and resulted in normal findings. The patient's pregnancy test was positive on Nov 10, 2020.

Other Meds:

Current Illness:

ID: 1605039
Sex: M
Age: 65
State: DC

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sleepy; woozy; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (woozy) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011a21a) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included AMLODIPINE, LISINOPRIL and ATENOLOL for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced DIZZINESS (woozy). At the time of the report, DIZZINESS (woozy) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. No treatment information was provided by the reporter. This case was linked to MOD-2021-070732 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Follow-up information received on 08-Jul-2021 contains .

Other Meds: AMLODIPINE; LISINOPRIL; ATENOLOL

Current Illness:

ID: 1605040
Sex: F
Age: 83
State: AL

Vax Date: 01/28/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: moderate reaction; red bad rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (moderate reaction) and INJECTION SITE RASH (red bad rash at injection site) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (moderate reaction) and INJECTION SITE RASH (red bad rash at injection site). At the time of the report, ADVERSE REACTION (moderate reaction) and INJECTION SITE RASH (red bad rash at injection site) had not resolved. Not Provided mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date. Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2021-020908 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-020908:Crosslinked (First dose)

Other Meds:

Current Illness:

ID: 1605041
Sex: M
Age: 65
State: DC

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (felt a pain/sensation from the top of his right arm to his right elbow) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 011A21A) for COVID-19 immunization. Concomitant products included amlodipine, lisinopril and atenolol for an unknown indication. On Feb 26, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 26, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 26, 2021, after the mRNA-1273 (Moderna COVID-19 vaccine), patient experienced pain in extremity (felt a pain/sensation from the top of his right arm to his right elbow). On Mar 31, 2021, pain in extremity (felt a pain/sensation from the top of his right arm to his right elbow) resolved. Treatment details not reported. This case linked to MOD-2021-070694 (patient link).

Other Meds: Amlodipine; Lisinopril; Atenolol

Current Illness:

ID: 1605042
Sex: F
Age:
State: IN

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site (right deltoid) warm to the touch; Injection site (right deltoid) swelling, itching; Injection site (right deltoid) swelling; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE WARMTH (Injection site (right deltoid) warm to the touch), VACCINATION SITE PRURITUS (Injection site (right deltoid) swelling, itching) and VACCINATION SITE SWELLING (Injection site (right deltoid) swelling) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. No Medical History information was reported. On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Injection site (right deltoid) warm to the touch), VACCINATION SITE PRURITUS (Injection site (right deltoid) swelling, itching) and VACCINATION SITE SWELLING (Injection site (right deltoid) swelling). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Injection site (right deltoid) warm to the touch), VACCINATION SITE PRURITUS (Injection site (right deltoid) swelling, itching) and VACCINATION SITE SWELLING (Injection site (right deltoid) swelling) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The reporter was a registered nurse who was calling on behalf of their patient who received their second dose of vaccination and had an adverse reaction. On 05-Apr-2021, the patient reached out to one of the registered nurses at the clinic and reported that they had injection site swelling, itching and it was warm to the touch. Reportedly, the reaction started approximately 5 hours post receiving the second dose. The patient also reported that they experienced the same reaction with the first dose as well. The patient was taking Benadryl at home. No Concomitant product use was reported. Action taken with mRNA-1273 in response to the event was not applicable. This case was linked to MOD-2021-070850 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow-up was received on 21-May-2021 and does not contain any new or significant information.

Other Meds:

Current Illness:

ID: 1605043
Sex: F
Age:
State: IN

Vax Date:
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site warmth; Injection site Itching; Injection site swelling; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE WARMTH (Injection site warmth), VACCINATION SITE PRURITUS (Injection site Itching) and VACCINATION SITE SWELLING (Injection site swelling) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site warmth), VACCINATION SITE PRURITUS (Injection site Itching) and VACCINATION SITE SWELLING (Injection site swelling). At the time of the report, VACCINATION SITE WARMTH (Injection site warmth), VACCINATION SITE PRURITUS (Injection site Itching) and VACCINATION SITE SWELLING (Injection site swelling) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Action taken with mRNA-1273 in response to the event was not applicable. No concomitant medications reported. Treatment medication included Benadryl. This case was linked to MOD-2021-070802 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow-up information received on 21-MAY-2021 contains no new information.

Other Meds:

Current Illness:

ID: 1605044
Sex: F
Age: 85
State: TN

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: weakness; Infection of a tick bite over the scalp, since after receiving the 1st shot of vaccine and the infection is now spreading down to patient's neck and shoulder and the infection is nowspreading down to patient's neck and shoulder; Infection of a tick bite over the scalp, since after receiving the 1st shot of vaccine and the infection is now spreading down to patient's neck and shoulder and the infection is nowspreading down to patient's neck and shoulder; feeling pretty bad; fatigue very tired and exhausted; chills; arm soreness; mild headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), ASTHENIA (weakness), ARTHROPOD BITE (Infection of a tick bite over the scalp, since after receiving the 1st shot of vaccine and the infection is now spreading down to patient's neck and shoulder and the infection is nowspreading down to patient's neck and shoulder), ARTHROPOD-BORNE DISEASE (Infection of a tick bite over the scalp, since after receiving the 1st shot of vaccine and the infection is now spreading down to patient's neck and shoulder and the infection is nowspreading down to patient's neck and shoulder) and FEELING ABNORMAL (feeling pretty bad) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. DZOBZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included VITAMINS NOS for an unknown indication. On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 25-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm soreness), HEADACHE (mild headache) and CHILLS (chills). On 01-Apr-2021, the patient experienced ASTHENIA (weakness), ARTHROPOD BITE (Infection of a tick bite over the scalp, since after receiving the 1st shot of vaccine and the infection is now spreading down to patient's neck and shoulder and the infection is nowspreading down to patient's neck and shoulder), ARTHROPOD-BORNE DISEASE (Infection of a tick bite over the scalp, since after receiving the 1st shot of vaccine and the infection is now spreading down to patient's neck and shoulder and the infection is nowspreading down to patient's neck and shoulder), FEELING ABNORMAL (feeling pretty bad) and FATIGUE (fatigue very tired and exhausted). On 31-Mar-2021, PAIN IN EXTREMITY (arm soreness), HEADACHE (mild headache) and CHILLS (chills) had resolved. At the time of the report, ASTHENIA (weakness), ARTHROPOD BITE (Infection of a tick bite over the scalp, since after receiving the 1st shot of vaccine and the infection is now spreading down to patient's neck and shoulder and the infection is nowspreading down to patient's neck and shoulder), ARTHROPOD-BORNE DISEASE (Infection of a tick bite over the scalp, since after receiving the 1st shot of vaccine and the infection is now spreading down to patient's neck and shoulder and the infection is nowspreading down to patient's neck and shoulder), FEELING ABNORMAL (feeling pretty bad) and FATIGUE (fatigue very tired and exhausted) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. Patient was on Concomitant products like Supplements and Natural medicine. Treatment information not provided. Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow up received on 16-JUN-2021 and contains information about the second dose.

Other Meds: VITAMINS NOS

Current Illness:

ID: 1605045
Sex: M
Age: 62
State: FL

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache a pain sale of 5 or 6/10.; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache a pain sale of 5 or 6/10.) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension. Concomitant products included LOSARTAN for Hypertension, HYDROCHLOROTHIAZIDE and METOPROLOL for an unknown indication. On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced HEADACHE (headache a pain sale of 5 or 6/10.). At the time of the report, HEADACHE (headache a pain sale of 5 or 6/10.) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment details included ibuprofen.

Other Meds: LOSARTAN; HYDROCHLOROTHIAZIDE; METOPROLOL

Current Illness: Hypertension

ID: 1605046
Sex: F
Age: 71
State: TX

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Felt achy with gradual aches that started building and worsening until her whole body felt tight and aching; Dry mouth; Chest pressure with heart burn that worsened as the night went on; Dry cough; Needs to frequent the bathroom to pee; left kidney was aching; lower back was aching; neck pain; Chest pressure with heart burn that worsened as the night went on; shoulders and arms aching; eyes feel dry and she feels like crap; shoulders and arms aching; Temperature of 99.4 degrees; Head hurts; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Apr-2021 and was forwarded to Moderna on 08-Apr-2021. This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Felt achy with gradual aches that started building and worsening until her whole body felt tight and aching), DRY MOUTH (Dry mouth), DYSPEPSIA (Chest pressure with heart burn that worsened as the night went on), COUGH (Dry cough) and MICTURITION URGENCY (Needs to frequent the bathroom to pee) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. Concomitant products included FLUTICASONE PROPIONATE (FLONASE) for Allergy, ATORVASTATIN for Cholesterol, GABAPENTIN for Fibromyalgia, OMEPRAZOLE and FAMOTIDINE for Heartburn, CITALOPRAM for Mood change, ACETYLSALICYLIC ACID (ASPIRIN 81), VITAMIN D [VITAMIN D NOS], FISH OIL, CYANOCOBALAMIN (Vitamin B12), CALCIUM, MAGNESIUM and ZINC for an unknown indication. On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced PAIN (Felt achy with gradual aches that started building and worsening until her whole body felt tight and aching), DRY MOUTH (Dry mouth), DYSPEPSIA (Chest pressure with heart burn that worsened as the night went on), COUGH (Dry cough), MICTURITION URGENCY (Needs to frequent the bathroom to pee), RENAL PAIN (left kidney was aching), BACK PAIN (lower back was aching), NECK PAIN (neck pain), CHEST DISCOMFORT (Chest pressure with heart burn that worsened as the night went on), PAIN IN EXTREMITY (shoulders and arms aching), DRY EYE (eyes feel dry and she feels like crap), ARTHRALGIA (shoulders and arms aching), PYREXIA (Temperature of 99.4 degrees) and HEADACHE (Head hurts). At the time of the report, PAIN (Felt achy with gradual aches that started building and worsening until her whole body felt tight and aching), DRY MOUTH (Dry mouth), DYSPEPSIA (Chest pressure with heart burn that worsened as the night went on), COUGH (Dry cough), MICTURITION URGENCY (Needs to frequent the bathroom to pee), RENAL PAIN (left kidney was aching), BACK PAIN (lower back was aching), NECK PAIN (neck pain), CHEST DISCOMFORT (Chest pressure with heart burn that worsened as the night went on), PAIN IN EXTREMITY (shoulders and arms aching), DRY EYE (eyes feel dry and she feels like crap), ARTHRALGIA (shoulders and arms aching), PYREXIA (Temperature of 99.4 degrees) and HEADACHE (Head hurts) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 99.4 degree Celsius (High) 99.4. The patient reports that these symptoms have not gone away yet. The patient is taking ibuprofen 200 mg to alleviate the symptoms. She took 2 before bed, and 3 later at night for aches. She had no further questions. Provided consent to follow-up. Concomitant product: Eye drops Unspecified for dry eyes

Other Meds: ATORVASTATIN; OMEPRAZOLE; GABAPENTIN; CITALOPRAM; FAMOTIDINE; ASPIRIN 81; VITAMIN D [VITAMIN D NOS]; FISH OIL; Vitamin B12; CALCIUM; MAGNESIUM; ZINC; FLONASE

Current Illness:

ID: 1605047
Sex: M
Age: 35
State: FL

Vax Date: 04/01/2021
Onset Date: 04/05/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash on his arms, arm pits, chest and back; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on his arms, arm pits, chest and back) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03B21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced RASH (Rash on his arms, arm pits, chest and back). At the time of the report, RASH (Rash on his arms, arm pits, chest and back) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was reported.

Other Meds:

Current Illness:

ID: 1605048
Sex: M
Age:
State: KS

Vax Date:
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Patient received his second dose 10 days earlier than due; This spontaneous case was reported by a physician and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (Patient received his second dose 10 days earlier than due) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products were not provided. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Patient received his second dose 10 days earlier than due). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (Patient received his second dose 10 days earlier than due) outcome was unknown. Not Provided Treatment products were not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1605049
Sex: F
Age: 34
State: VA

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Ankle very swollen; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Ankle very swollen) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced JOINT SWELLING (Ankle very swollen). At the time of the report, JOINT SWELLING (Ankle very swollen) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication reported. Treatment information not provided.

Other Meds:

Current Illness:

ID: 1605050
Sex: F
Age: 44
State: TX

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: cough; sore throat; very nauseated; fatigue; dizzy; sick; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), ILLNESS (sick), COUGH (cough), OROPHARYNGEAL PAIN (sore throat) and NAUSEA (very nauseated) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced DIZZINESS (dizzy) and ILLNESS (sick). On an unknown date, the patient experienced COUGH (cough), OROPHARYNGEAL PAIN (sore throat), NAUSEA (very nauseated) and FATIGUE (fatigue). At the time of the report, DIZZINESS (dizzy), ILLNESS (sick), COUGH (cough), OROPHARYNGEAL PAIN (sore throat), NAUSEA (very nauseated) and FATIGUE (fatigue) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, SARS-CoV-1 test: positive (Positive) positive [rapid antigen test for COVID]. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication provided. There is no treatment taken.; Sender's Comments: Based on the current available information and the temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded. However, Based on the mechanism of action of mRNA -1273, causal association between the event of SAR-COV-2 test positive and mRNA-1273 is assessed as not applicable.

Other Meds:

Current Illness:

ID: 1605051
Sex: M
Age: 75
State: FL

Vax Date: 01/15/2021
Onset Date: 03/29/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore left arm; Nerve pain; Itching; shingles; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore left arm), HERPES ZOSTER (shingles), NEURALGIA (Nerve pain) and PRURITUS (Itching) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure high, High cholesterol, Type 2 diabetes mellitus and Allergy to antibiotic. Concomitant products included METFORMIN, ATORVASTATIN, TELMISARTAN, ASPIRIN [ACETYLSALICYLIC ACID] and CARVEDILOL (COREG) for an unknown indication. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced HERPES ZOSTER (shingles). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore left arm), NEURALGIA (Nerve pain) and PRURITUS (Itching). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency; GABAPENTIN for Nerve pain, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Sore left arm), NEURALGIA (Nerve pain) and PRURITUS (Itching) outcome was unknown and HERPES ZOSTER (shingles) had not resolved. Not Provided Treatment details include antiviral drug as per his dermatologist. . Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Significant follow up

Other Meds: METFORMIN; ATORVASTATIN; TELMISARTAN; ASPIRIN [ACETYLSALICYLIC ACID]; COREG

Current Illness: Allergy to antibiotic; Blood pressure high; High cholesterol; Type 2 diabetes mellitus

ID: 1605052
Sex: M
Age: 63
State: CA

Vax Date: 04/06/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Runny nose after 2nd dose; Sore arm after 2nd dose; Headache after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose after 2nd dose), PAIN IN EXTREMITY (Sore arm after 2nd dose) and HEADACHE (Headache after 2nd dose) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. No Medical History information was reported. On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (Runny nose after 2nd dose), PAIN IN EXTREMITY (Sore arm after 2nd dose) and HEADACHE (Headache after 2nd dose). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (Runny nose after 2nd dose), PAIN IN EXTREMITY (Sore arm after 2nd dose) and HEADACHE (Headache after 2nd dose) had resolved. No concomitant medications were reported. Action taken with mRNA-1273 in response to the events was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Outcome of events were updated.

Other Meds:

Current Illness:

ID: 1605053
Sex: M
Age: 64
State: FL

Vax Date: 03/01/2021
Onset Date: 04/08/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Had fever (100.9?F); Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Had fever (100.9?F)) and FATIGUE (Fatigue) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B and 036A21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included SINUPROL for Heart disorder, LISINOPRIL and OMEPRAZOLE for an unknown indication. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced PYREXIA (Had fever (100.9?F)) and FATIGUE (Fatigue). At the time of the report, PYREXIA (Had fever (100.9?F)) and FATIGUE (Fatigue) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Body temperature: 100.9 degree f (High) 100.9 degree F. No treatment information was provided.

Other Meds: LISINOPRIL; OMEPRAZOLE; SINUPROL

Current Illness:

ID: 1605054
Sex: M
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lost taste; Lost smell; Got very sick; This spontaneous case was reported by an other caregiver and describes the occurrence of AGEUSIA (Lost taste), ANOSMIA (Lost smell) and ILLNESS (Got very sick) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AGEUSIA (Lost taste), ANOSMIA (Lost smell) and ILLNESS (Got very sick). At the time of the report, AGEUSIA (Lost taste), ANOSMIA (Lost smell) and ILLNESS (Got very sick) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Tested positive for Covid infection. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to MOD-2021-071416, MOD-2021-072067, MOD-2021-070997, MOD-2021-077195, MOD-2021-071383 (Patient Link).

Other Meds:

Current Illness:

ID: 1605055
Sex: F
Age:
State: CO

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Aches; FEVER; Vomiting; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches), PYREXIA (FEVER), VOMITING (Vomiting), NAUSEA (Nausea) and HEADACHE (Headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. Concurrent medical conditions included Thyroid disorder. On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced PAIN (Aches), PYREXIA (FEVER), VOMITING (Vomiting), NAUSEA (Nausea) and HEADACHE (Headache). At the time of the report, PAIN (Aches), PYREXIA (FEVER), VOMITING (Vomiting), NAUSEA (Nausea) and HEADACHE (Headache) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporte

Other Meds:

Current Illness: Thyroid disorder

ID: 1605056
Sex: F
Age: 88
State: CA

Vax Date: 02/08/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at the injection site) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain at the injection site). At the time of the report, VACCINATION SITE PAIN (pain at the injection site) outcome was unknown. Not Provided. No concomitant and treatment information was reported by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Follow up document is received on 13-MAY-2021 and it doesn't have any new information.

Other Meds:

Current Illness:

ID: 1605057
Sex: M
Age:
State: CA

Vax Date: 03/11/2021
Onset Date: 04/03/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: running nose; possible sore throat; Cold; coughing; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (running nose), OROPHARYNGEAL PAIN (possible sore throat), NASOPHARYNGITIS (Cold) and COUGH (coughing) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. Concurrent medical conditions included Seasonal allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, the patient experienced RHINORRHOEA (running nose), OROPHARYNGEAL PAIN (possible sore throat), NASOPHARYNGITIS (Cold) and COUGH (coughing). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (running nose), OROPHARYNGEAL PAIN (possible sore throat), NASOPHARYNGITIS (Cold) and COUGH (coughing) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: ZYRTEC ALLERGY

Current Illness:

ID: 1605058
Sex: M
Age: 50
State: OH

Vax Date: 03/24/2021
Onset Date: 03/29/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: may have been little weak for 7-10 days; felt a little run down; headache-pain behind eyes; Loss of taste after the 1st dose; Loss of smell; Diagnosed with COVID-19 after 1st dose; feel sick; runny nose; nasal congestion; diarrhea; cough; nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with COVID-19 after 1st dose), MALAISE (feel sick), AGEUSIA (Loss of taste after the 1st dose), ANOSMIA (Loss of smell) and RHINORRHOEA (runny nose) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017821A and 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Hypertension since 1996, Diabetes since 2012, Obesity, Acid reflux (oesophageal) since 1996 and Gout since 1999. Concomitant products included METFORMIN from 2012 to an unknown date and PIOGLITAZONE HYDROCHLORIDE (ACTOS) for Diabetes, ALLOPURINOL for Gout, METOPROLOL from 1996 to an unknown date and LOSARTAN POTASSIUM (LOSARTAN POTASSIUM) for Hypertension. On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced MALAISE (feel sick). On 02-Apr-2021, the patient experienced COVID-19 (Diagnosed with COVID-19 after 1st dose). On 02-Apr-2021 at 6:00 AM, the patient experienced AGEUSIA (Loss of taste after the 1st dose), ANOSMIA (Loss of smell) and HEADACHE (headache-pain behind eyes). On 04-Apr-2021, the patient experienced FEELING ABNORMAL (felt a little run down). On 16-Apr-2021, the patient experienced ASTHENIA (may have been little weak for 7-10 days). On an unknown date, the patient experienced RHINORRHOEA (runny nose), NASAL CONGESTION (nasal congestion), DIARRHOEA (diarrhea), COUGH (cough), NAUSEA (nausea) and VOMITING (Vomiting). The patient was treated with GUAIFENESIN (ROBITUSSIN [GUAIFENESIN]) (oral) at an unspecified dose and frequency; CHLORPHENAMINE MALEATE, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (TYLENOL COLD + FLU) (oral) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 12-Apr-2021, AGEUSIA (Loss of taste after the 1st dose) and ANOSMIA (Loss of smell) had resolved. On 15-Apr-2021, HEADACHE (headache-pain behind eyes) had resolved. On 16-Apr-2021, FEELING ABNORMAL (felt a little run down) had resolved. At the time of the report, COVID-19 (Diagnosed with COVID-19 after 1st dose), MALAISE (feel sick) and ASTHENIA (may have been little weak for 7-10 days) outcome was unknown and RHINORRHEA (runny nose), NASAL CONGESTION (nasal congestion), DIARRHEA (diarrhea), COUGH (cough), NAUSEA (nausea) and VOMITING (Vomiting) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Apr-2021, Polymerase chain reaction positive: positive (Positive) positive. On an unknown date, Blood pressure measurement: <90/<60 mmHg (Low) low. Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Updated reporter details,patient demographics, past medical history, lab data, suspect product dose 1 route of administration,anatomical location,dose 2 details concomitant, treatment medications and events were added.

Other Meds: Metformin; Metoprolol; Allopurinol; Losartan Potassium; Actos

Current Illness: Acid reflux (oesophageal); Diabetes; Gout; Hypertension; Obesity.

ID: 1605059
Sex: F
Age: 38
State: OH

Vax Date: 04/01/2021
Onset Date: 04/07/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Felt more sickness; Symptoms of sicker stomach; Strange taste in the mouth; Feeling cold; Loss of smell; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Felt more sickness), ABDOMINAL DISCOMFORT (Symptoms of sicker stomach), DYSGEUSIA (Strange taste in the mouth), FEELING COLD (Feeling cold) and ANOSMIA (Loss of smell) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced ILLNESS (Felt more sickness), ABDOMINAL DISCOMFORT (Symptoms of sicker stomach), DYSGEUSIA (Strange taste in the mouth), FEELING COLD (Feeling cold) and ANOSMIA (Loss of smell). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ILLNESS (Felt more sickness), ABDOMINAL DISCOMFORT (Symptoms of sicker stomach), DYSGEUSIA (Strange taste in the mouth), FEELING COLD (Feeling cold) and ANOSMIA (Loss of smell) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient was pending for a Covid test report. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1605060
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: vertigo; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo), PYREXIA (fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VERTIGO (vertigo), PYREXIA (fever) and CHILLS (chills). At the time of the report, VERTIGO (vertigo), PYREXIA (fever) and CHILLS (chills) outcome was unknown. No Concomitant medications were provided. No Treatment History was provided.

Other Meds:

Current Illness:

ID: 1605061
Sex: F
Age: 73
State: NJ

Vax Date: 03/10/2021
Onset Date: 04/08/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is aching), PAIN IN EXTREMITY (sore arm), PAIN (Body aches), INJECTION SITE PRURITUS (Arm was often itchy in the area of the shot) and CHILLS (Chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Allergy to antibiotic (augmentin), Blood pressure high (since many years), High cholesterol (since many years), Acid reflux (oesophageal) (since many years), Anxiety depression (since many years) and Breast cancer since 2017. Concomitant products included OMEPRAZOLE for Acid reflux (oesophageal), METOPROLOL for Blood pressure high, ANASTROZOLE (ARIMIDEX) for Breast cancer, SERTRALINE HYDROCHLORIDE (ZOLOFT) for Depression, SIMVASTATIN (ZOCOR) for High cholesterol. On 10-Mar-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm is aching) and HEADACHE (Headache). On 08-Apr-2021 at 6:00 AM, the patient experienced PAIN (Body aches), CHILLS (Chills) and PYREXIA (Fever). On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On an unknown date, the patient experienced INJECTION SITE PRURITUS (Arm was often itchy in the area of the shot). On 08-Apr-2021, PAIN (Body aches), CHILLS (Chills) and PYREXIA (Fever) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm is aching) and HEADACHE (Headache) outcome was unknown and PAIN IN EXTREMITY (sore arm) and INJECTION SITE PRURITUS (Arm was often itchy in the area of the shot) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Follow up was received include event, concomitant medications, patients demographics updated.

Other Meds: METOPROLOL; ZOCOR; OMEPRAZOLE; ZOLOFT; ARIMIDEX

Current Illness: Acid reflux (oesophageal) (since many years); Allergy to antibiotic (augmentin); Anxiety depression (since many years); Blood pressure high (since many years); Breast cancer; High cholesterol (since many years)

ID: 1605062
Sex: F
Age: 75
State: MI

Vax Date: 03/09/2021
Onset Date: 04/08/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: red spot the side of a tennis ball at the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Apr-2021 and was forwarded to Moderna on 08-Apr-2021. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red spot the side of a tennis ball at the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 030A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (red spot the side of a tennis ball at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (red spot the side of a tennis ball at the injection site) outcome was unknown. No concomitant medication information provided. No treatment information provided.

Other Meds:

Current Illness:

ID: 1605063
Sex: F
Age: 69
State: CA

Vax Date: 03/05/2021
Onset Date: 04/02/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Feeling ill / Malaise; Sick in bed all day; Lot of pain that she described as flu-like; Fatigue; Sore arm; Not sleeping well; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), MALAISE (Feeling ill / Malaise), ILLNESS (Sick in bed all day), INFLUENZA LIKE ILLNESS (Lot of pain that she described as flu-like) and INSOMNIA (Not sleeping well) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046a21a and 029a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. Concomitant products included MULTIVITAMINS [VITAMINS NOS], SELEGILINE (EMSAM) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and INSOMNIA (Not sleeping well). On 03-Apr-2021, the patient experienced MALAISE (Feeling ill / Malaise), ILLNESS (Sick in bed all day), INFLUENZA LIKE ILLNESS (Lot of pain that she described as flu-like) and FATIGUE (Fatigue). On 03-Apr-2021, ILLNESS (Sick in bed all day) had resolved. On 04-Apr-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, MALAISE (Feeling ill / Malaise), INFLUENZA LIKE ILLNESS (Lot of pain that she described as flu-like), INSOMNIA (Not sleeping well) and FATIGUE (Fatigue) outcome was unknown. Not Provided The patient believes the vaccine triggered her immune system to experience a fight or flight response. She states her immune system doesn't cope well with viruses. Patient states she would be hesitant to take ever take the vaccine again. Treatment details included Aspirin to cope with the pain.

Other Meds: MULTIVITAMINS [VITAMINS NOS]; EMSAM; ASPIRIN (E.C.)

Current Illness:

ID: 1605064
Sex: F
Age: 31
State: FL

Vax Date: 04/02/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Broke into target hives after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Broke into target hives after vaccination) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Broke into target hives after vaccination). At the time of the report, URTICARIA (Broke into target hives after vaccination) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Broke into target hives after vaccination) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Broke into target hives after vaccination). At the time of the report, URTICARIA (Broke into target hives after vaccination) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1605065
Sex: M
Age:
State: NY

Vax Date: 04/05/2021
Onset Date: 04/07/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness; Weakness; Feels like I am going to fall down when I am standing; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS, ASTHENIA, and PRESYNCOPE in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced DIZZINESS, ASTHENIA, and PRESYNCOPE. At the time of the report, DIZZINESS, ASTHENIA, and PRESYNCOPE outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown. No relevant concomitant medications were reported. No treatment information was reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1605066
Sex: F
Age: 33
State: VA

Vax Date: 04/06/2021
Onset Date: 04/08/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: ulcers on top of and under her tongue.; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of ULCER (ulcers on top of and under her tongue.) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced ULCER (ulcers on top of and under her tongue.). At the time of the report, ULCER (ulcers on top of and under her tongue.) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient received the vaccination about 48 hours ago and has developed ulcers on top of and under her tongue.

Other Meds:

Current Illness:

ID: 1605067
Sex: F
Age: 63
State: CA

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of feeling abnormal (felt loopy), abnormal thinking (couldn't think straight for a day) and pounding headache in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included no adverse event. On Mar 9, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 9, 2021, patient experienced feeling abnormal (felt loopy), abnormal thinking (couldn't think straight for a day) and pounding headache. At the time of the report, feeling abnormal (felt loopy), abnormal thinking (couldn't think straight for a day) and pounding headache outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant products usage and treatment details not included.

Other Meds:

Current Illness:

ID: 1605068
Sex: F
Age: 33
State:

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) in a 33-year-old female patient (gravida 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination. No Medical History information was reported. On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 19-Aug-2020 and the estimated date of delivery was 17-Jun-2021. On 07-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the thirty-third week of the pregnancy. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient reported that she is not under medications.

Other Meds:

Current Illness:

ID: 1605069
Sex: M
Age:
State: AZ

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; Body ache; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PAIN (Body ache) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), PAIN (Body ache) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (sore arm), PAIN (Body ache) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was reported ,No treatment medication was reported .

Other Meds:

Current Illness:

ID: 1605070
Sex: M
Age: 70
State: NY

Vax Date: 01/20/2021
Onset Date: 01/25/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: not received the 2nd vaccine; covid-19 virus test positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (covid-19 virus test positive) and PRODUCT DOSE OMISSION ISSUE (not received the 2nd vaccine) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (covid-19 virus test positive). On 08-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (not received the 2nd vaccine). At the time of the report, SARS-COV-2 TEST POSITIVE (covid-19 virus test positive) and PRODUCT DOSE OMISSION ISSUE (not received the 2nd vaccine) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Coronavirus test: (Positive) positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. Treatment included a monoclonal infusion

Other Meds:

Current Illness:

ID: 1605071
Sex: F
Age: 69
State:

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chills; fever; Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever) and INFLUENZA LIKE ILLNESS (Flu like symptoms) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included HYDROCODONE BITARTRATE, PARACETAMOL (NORCO), GABAPENTIN, TOPIRAMATE (TOPAMAX), DULOXETINE HYDROCHLORIDE (CYMBALTA), METOPROLOL SUCCINATE, ATORVASTATIN CALCIUM (LIPITOR), Low-Dose Aspirin and ALPRAZOLAM (XANAX) for an unknown indication. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced CHILLS (chills), PYREXIA (fever) and INFLUENZA LIKE ILLNESS (Flu like symptoms). On 14-Mar-2021, CHILLS (chills), PYREXIA (fever) and INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant products included Norco, Gabapentin, Topamax, Cymbalta,Metoprolol Succinate, Lipitor, Low-Dose Aspirin, Xanax. Reporter did not allow further contact

Other Meds: NORCO; GABAPENTIN; TOPAMAX; CYMBALTA; METOPROLOL SUCCINATE; LIPITOR; Low-Dose Aspirin; XANAX

Current Illness:

ID: 1605072
Sex: F
Age: 63
State: LA

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash; mild headache; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) and HEADACHE (mild headache) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). Concomitant products included CALCIUM and POTASSIUM for an unknown indication. On 08-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced RASH (Rash) and HEADACHE (mild headache). At the time of the report, RASH (Rash) and HEADACHE (mild headache) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication include diabetes medication. Treatment information not provided.

Other Meds: CALCIUM; POTASSIUM

Current Illness:

ID: 1605073
Sex: F
Age: 39
State: MN

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm is sore; bump on her finger that feels like it's getting worse; nightmares; This spontaneous case was reported by a consumer and describes the occurrence of NIGHTMARE (nightmares), MYALGIA (arm is sore) and PERIPHERAL SWELLING (bump on her finger that feels like it's getting worse) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included SUMATRIPTAN SUCCINATE (IMITREX DF) for an unknown indication. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced NIGHTMARE (nightmares). On 24-Mar-2021, the patient experienced MYALGIA (arm is sore) and PERIPHERAL SWELLING (bump on her finger that feels like it's getting worse). At the time of the report, NIGHTMARE (nightmares), MYALGIA (arm is sore) and PERIPHERAL SWELLING (bump on her finger that feels like it's getting worse) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medication was reported .

Other Meds: IMITREX DF

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 03 October 2021 5:28pm